Professional Documents
Culture Documents
S100 2018 01scrip 100 League Table ONLINE
S100 2018 01scrip 100 League Table ONLINE
S100 2018 01scrip 100 League Table ONLINE
Merck & Co3 35,151.0 -2.8% 4 (4) CSL 5,909.0 5.0% 29 (29)
Johnson & Johnson 33,464.0 6.5% 6 (7) Sun Pharmaceutical 4,505.3 9.8% 31 (32)
Teva 21,903.0 11.5% 10 (12) Mitsubishi Tanabe Pharma 3,898.0 10.3% 35 (36)
1
Excludes $3.407bn in OTC drugs Healthcare segment
8
2
Innovative Pharma plus Sandoz Excludes OTC
9
3
Excludes Animal Health, Healthcare Services and Consumer Care 10
Established Pharmaceuticals
4
Boosted by Opdivo sales 11
$2843m revenue are Soliris
Includes 7 months of revenue from generics business sold to Teva: Excludes
5 12
Excludes oxycodone and hydrocodone API
sales of fillers and breast Implants 13
IV drugs
6
Prescription Medicines division 14
Before acquisition by J&J
7
Acquistion of Baxalta 15
Excludes API sales
16
Hospital products, Integrated Pharmacy Solutions
6 SCRIP100.COM
SCRIP 100
PHARMA SALES CHANGE RANK 2016 PHARMA SALES CHANGE RANK 2016
COMPANY ($M) 2016 FROM 2015 (2015) COMPANY ($M) 2016 FROM 2015 (2015)
Ono Pharmaceutical17 1,970.3 37.7% 51 (60) Galenica AG27 1,184.6 34.9% 76 (96)
Santen Pharmaceutical 1,686.8 12.5% 55 (56) Sawai Pharmaceutical31 1,117.5 21.4% 80 (93)
Vertex Pharmaceuticals19 1,683.6 68.3% 56 (83) BioMarin Pharmaceutical 1,110.4 25.5% 81 (95)
Zhejiang Hisun Pharma 1,465.2 4.0% 65 (61) Alvogen Pharmaceuticals36 1,000.0 25.0% 90 (99)
Gedeon Richter 1,384.3 25.1% 69 (77) Shanghai Pharmaceutical39 926.6 0.5% 94 (92)
Glenmark Pharmaceuticals 1,223.9 3.4% 73 (73) Taisho Pharmaceutical 41 883.5 -0.2% 98 (94)
Kowa Pharmaceutical 1,200.0 0.0% 75 (71) Amneal Pharmaceuticals43 875.0 0.0% 100 (97)
SCRIP100.COM 7